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Dermatomyositis-related intestinal dysmotility
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ABSTRACT
Dermatomyositis (DM) is an inflammatory myopathy (IIM) characterized by proximal muscle weakness and pathognomonic skin lesions. A
69-year-old woman with a recent diagnosis of DM 1 month prior, treated with corticosteroids and immunomodulators, presented to our inpatient
rehabilitation with worsening dysphagia and constipation. At the time of our evaluation, physical examination was notable for erythematous
papules over the metacarpophalangeal joints, proximal interphalangeal joints, elbows, and knees as well as a violaceous rash on the face.
Muscle strength was diminished bilaterally with proximal distribution being affected greater than distal. Laboratory studies were notable for the
creatine kinase (CK) level of 31 IU/l, antinuclear antibodies (ANA) by immunofluorescence of 1:80, and aldolase 4 u/l. The 11-antibody myositis
panel was negative showed partially treated acquired IIM with perifascicular atrophy. During hospitalisation, she was found to have pulmonary
embolism. She received enoxaparin 1 mg/kg subcutaneous BID. Soon after, she developed rectal bleeding. Colonoscopy showed a stercoral ulcer
caused by chronic constipation. While dysphagia is common, being present in 25–50% of patients with DM, lower gastrointestinal problems
involving the small and large intestine are rare and typically present as a late manifestation of the disease. Decreased peristalsis in the large colon
can lead to constipation, impaction, and subsequent mucosal ulceration, and pressure necrosis induced by faecaloma formation. Although rare,
our case highlights the importance of recognising gastrointestinal complications that DM can cause and the effects that those complications
have on morbidity and mortality.
KEYWORDS: Dermatomyositis; intestinal dysmotility; myopathy-related constipation; gastrointestinal bleeding

Introduction
Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM) that is caused by immune-mediated muscle inflammation characterised by proximal muscle weakness and skin
involvement typically affecting the extensor surfaces of the
hands and face. Given its protean clinical manifestations
and recently recognised serological profiles, different subtypes
have been identified for the classification of DM. DM usually appears in the adolescent period and between 40 and
60 years of age, with a female predominant pattern [2, 10].
The aetiology of DM has been thought to be idiopathic or
associated to an underlying neoplastic process [2]. Other
organ manifestations have also been described, including the
blood vessels, lungs, oesophagus, joints [3], and rarely the
lower gastrointestinal tract, affecting the motility of the colon
[4]. We present a case of DM associated with slow bowel
transit inducing constipation and subsequent gastrointestinal
bleeding in an otherwise healthy woman.

Case report
A 69-year-old woman presented to her primary care physician due to inability to comb her hair secondary to left upper
extremity weakness and a new onset rash to the extensor
surfaces of metacarpophalangeal joints (MCPs), proximal

interphalangeal joints (PIPs), elbows, knees, and her face.
The patient underwent laboratory tests, which showed an
ANA titre 1:640 by immunofluorescence, negative anti-Jo1 and anti-Mi2 antibodies. Given her clinical presentation,
the patient was diagnosed with inflammatory myositis. The
patient was started on pulse methylprednisolone at 1 mg/day
for 3 days. Following completion of the pulse therapy, the
patient was sent home to continue prednisone 50 mg orally
daily along with azathioprine 50 mg orally twice daily. The
patient did have an improvement in her rash and some of
her proximal muscle weakness; however, about 1 month
later the patient was taken to an outside hospital due to
worsening dysphagia and severe constipation. The patient
underwent laboratory tests, which showed normal levels
of creatine kinase (CK) of 34 IU/l, the sedimentation rate
of 32 mm/h, aldolase of 2.7 u/l, negative anti-smith, antidouble stranded-DNA, anti-RNP, anti-SS-A, anti-SS-B, and
anti-neutrophilic cytoplasmic antibodies. At that time, the
patient was found to have severe fecal impaction (Figures 8–9)
and colonoscopy was attempted three times due to poor bowel
preparation and the patient had to be manually disimpacted.
The patient eventually underwent a successful colonoscopy
with polypectomy of three polyps. Pathology showed that
all three polyps were benign adenomas. Due to continued
dysphagia, the patient underwent an esophagogastroduodenoscopy, which showed an oesophageal ring. The patient
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Figure 2. No abnormal inclusions or rimmed vacuole-type structures
noted on modified gomori trichome preparation.

Figure 3. NADH-TR stain showing occasional targetoid muscle fibres.

Figure 4. Esterase stain showing atrophic muscle fibres and highlights
and occasional macrophages within the perimysium.

Figure 1. H&E stain showing a mild-to-moderate increase in perimysial
connective tissue, with variation in the fibre diameter due to the
presence of frequently angulated and atrophic muscle fibres, frequent
regenerating muscle fibres, and occasional necrotic muscle fibres.

emboli. The patient was started on full dose anticoagulation with enoxaparin at 1 mg/kg subcutaneous BID. Four
days after starting treatment, the patient was transferred from
inpatient rehabilitation to our emergency department due to
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subsequently underwent jejunostomy tube placement. The
patient was transferred to our inpatient rehabilitation centre
for physical therapy 1 month after her initial presentation, for
which our rheumatology team was consulted. Upon our questioning, the patient noted that she was well up until about
one and a half months prior to current admission. Prior to
that, the patient did endorse an unintentional 30-lb weight
loss but did not have any night sweats, cough, haemoptysis, haematochezia, vaginal bleeding, melena, early satiety,
or any other worrisome symptoms. She reported that all her
age-appropriate cancer screenings were performed in Mexico
and that everything was ‘normal’. Our physical examination
was notable for erythematous papules over the MCPs, PIPs,
elbows, and knees as well as a violaceous rash on the face
not sparing the nasolabial folds (Figures 10–11). Her muscle
strength was diminished bilaterally in a proximal and distal distribution; however, proximal was more affected being
3/5 strength compared to 4/5 strength, respectively. Laboratory studies were notable for a TSH of 22 uIU/ml, the CK
level of 31 IU/l, the sedimentation rate of 34 mm/h, ANA by
immunofluorescence of 1:80, negative anti-Scl-70 antibody,
and aldolase 4 u/l. The 11-antibody myositis panel showed
negative anti-EJ, anti-Jo-1, anti-MDA-5, anti-Mi-2 Alpha,
anti-Mi-2 Beta, anti-NXP-2, anti-OJ, anti-PL-12, anti-Pl-7,
anti-SRP and anti-TIF-1 gamma antibodies. Skeletal muscle
biopsy of the left thigh was performed,
which showed
partially treated acquired IIM with perifascicular atrophy
(Figures 1–5). The patient had a calculated myositis diagnostic score based on the European League Against Rheumatism
(EULAR)/American College of Rheumatology (ACR) Classification Criteria for Idiopathic Inflammatory Myopathies
of 18.8 out of 19 with a 100% probability of IIM. Due to
continued weakness, the patient was started on methylprednisolone 40 mg IV every 24 h along with azathioprine 50 mg
BID. During the hospital stay, the patient began to complain of shortness of breath and was noted to be tachycardic.
Venous Doppler of bilateral lower extremities was performed
along with chest angiogram, which showed bilateral lower
extremity deep venous thrombi and multifocal pulmonary
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Figure 8. Abdominal XR showing evidence of constipation.

Figure 6. Colonoscopy showing rectal ulcer.

Figure 9. CT abdomen/Pelvis showing large stool burden with fecal
impaction.

Figure 7. Colonoscopy showing rectal ulcer.

haematochezia. The patient was found to have a decrease
in her haemoglobin from 11 to 8.8 g/dl. She underwent a
repeat colonoscopy and was found to have a 1-cm rectal
ulcer (Figures 6–7) with hallmark features consistent with a

stercoral ulcer suspected to be caused by chronic constipation secondary to impaired peristalsis in the setting of DM.
Anticoagulation was discontinued and the patient underwent
the placement of an inferior vena cava (IVC) filter. Computed
tomography scan results of abdomen and chest were negative for masses or lymphadenopathies. The patient continues treatment with methylprednisolone 40 mg IV twice daily
via jejunostomy, methotrexate 7.5 mg weekly, and azathioprine 50 mg twice daily. She has not had recurrence of rectal
bleeding; however, she continues to have difficulty with constipation and dysphagia. Currently, she can swallow thick liquids such as pudding. Her limb involvement has significantly
improved, and she is now able to ambulate without assistance.
Even though there was no identifiable malignancy found, the
presence of venous thrombus emboli increases suspicion for
malignancy that has not yet been identified. The malignancy
can precede, is concurrent with, or follows the diagnosis
of DM.
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Figure 5. Alkaline phosphatase preparation demonstrates a patchy mild
increase in capillary staining and highlights regenerating necrotic muscle
fibres located in the perifascilar distribution.
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Discussion

Figure 11. Erythematous papules over PIPs and MCPs.
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Figure 10. Violaceous rash not sparing nasolabial folds.

DM is an inflammatory muscle disease that typically affects
skeletal muscles and presents proximal weakness. The characteristic skin manifestations include rash particularly in the
dorsa of the hands, face, V of the neck, lateral aspect of
the thighs, and periungual erythema or possible ulcerated
papules. Patients can also manifest occasional fever, weight
loss, arthralgia, and gastrointestinal abnormalities. The latter usually refers to motility issues that arise from the striate
muscle in the oesophagus and typically presents as dysphagia. While dysphagia is common being present in 25–50% of
patients with DM, lower gastrointestinal problems involving
the small and large intestine are rare and typically present as
a late manifestation of the disease. DM-related dysphagia is
caused by inflammatory involvement of the muscles involved
in swallowing. According to the literature, DM-related dysphagia can be classified as proximal versus distal based on the
type of muscle involved. Proximal dysphagia occurs due to the
involvement of striated muscles of the pharynx or upper onethird oesophagus whereas distal dysphagia involves smooth
muscle and is typically associated with other connective tissue
diseases such as systemic sclerosis [5]. The involvement of the
upper oesophagus and cricopharyngeal muscle leads to dysphonia and difficulty swallowing. In contrast, distal involvement presents with delayed gastric emptying and dysmotility,
which can cause recurrent abdominal pain and bloody diarrhoea. Radiologically these can manifest as dilated atonic
oesophagus, thickening of the small bowel wall, or ‘stacked
coin’ appearance. There are four degrees of dysphagia in DM
based on the patient’s symptoms and clinical findings ranging
from nonobvious complaints up to severe dysphagia requiring
feeding tubes. Our patient’s dysphagia would be classified as
degree 4 as she required the placement of jejunostomy tube
for nutrition. It is important to note that dysphagia not only
decreases the quality of life in patients diagnosed with DM,
but it can also increase mortality due to complications such
as aspiration pneumonia and malnutrition [5]. Immunosuppressive therapy with corticosteroids and intravenous immune
globulin (IVIG) significantly improves proximal dysphagia;
however, distal dysphagia treatment is more challenging and
further research needs to be conducted to determine the best
treatment approach [1, 9].
As mentioned above, lower gastrointestinal involvement
in DM is rare; however, there have been a few cases published in the literature. Gadiparthi and associates described an
association between inflammatory myopathies and intestinal
pseudo-obstruction, which clinically presented with recurrent
obstructive symptoms but lacked evidence of a mechanical
obstruction [6]. Levesque et al. described a case of a young
patient with DM who presented with dysphagia and melena
and was found to have multiple ulcerations in the oesophagus and the duodenum. Unlike our patient, histopathology
of the ulcerations showed evidence of vasculitis [7]. Several other cases of lower gastrointestinal tract involvement
have been reported including the study by Tweezer-Zaks
et al. who performed a retrospective review on the clinical
course of 48 patients diagnosed with polymyositis and DM
and identified patients with severe gastrointestinal manifestations. Of the 48 patients within the study population, only
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Conclusion
Although rare, our case highlights the importance of recognising gastrointestinal complications that DM can cause and
the effects that these complications have on morbidity and
mortality. Patients admitted in the inpatient setting with DM
should have an aggressive bowel regimen to help decrease
complications from intestinal dysmotility. It is also important
that these patients work with physical therapy and occupational therapy to decrease the risk of functional debility. The
literature is limited regarding DM gastrointestinal complications; thus, it is important to report similar cases to determine
the best treatment strategies to mitigate complications such as
the one presented here.
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three patients presented with lower gastrointestinal manifestation, which included findings of the oedematous hyperaemic
bowel wall with multiple erosions and ulcerous lesions on
endoscopy. Histologically, these lesions consisted of diffuse
mucosal inflammation and multiple vascular ectasias without
evidence of vasculitis [8]. Similarly, our patient’s colonoscopy
showed a stercoral ulcer at the rectum, which resulted in
lower gastrointestinal bleeding. Muscular inflammation in
DM can impair peristalsis throughout the gastrointestinal
tract. Decreased peristalsis in the large colon can lead to constipation, faecal impaction, and subsequent mucosal ulceration, and pressure necrosis induced by faecaloma formation.
Our patient was being treated with full dose anticoagulation for bilateral lower extremity deep venous and pulmonary
emboli. This along with severe faecal impaction was the
underlying mechanism that resulted in haematochezia in our
patient.
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